Clinical Trials Browser

Advanced Malignancies × HMPL-013 × 30 days × Clear all

NCT04164199 2026-06-03

Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies

Phase 3 Completed

Advanced Malignancies